Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
05/2003
05/02/2003EP1305414A2 Modified cea and uses thereof
05/02/2003EP1305402A1 Lipo-viro-particle complexes, preparation method and uses
05/02/2003EP1305039A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
05/02/2003EP1305038A2 Bacteriophage having multiple host range
05/02/2003EP0802983B1 Expression of urokinase plasminogen activator inhibitors
05/01/2003WO2003035889A2 Compositions and methods for bacteria detection
05/01/2003WO2003035681A2 Mycobacterial genes down-regulated during latency
05/01/2003WO2003035012A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003WO2003034981A2 Prevention of recurrent viral disease
05/01/2003WO2002100340A3 Improved vaccination against anthrax
05/01/2003US20030082790 Isolated enzymatic polypetide for use as tool in genetic engineering
05/01/2003US20030082789 Packaging plasmid for use as gene transfer tool in genetic engineering
05/01/2003US20030082788 Recombinant infectious laryngotracheitis virus and uses thereof
05/01/2003US20030082753 Generation of expression vector for use as gene transfer tool; prepare nutrient broth, inoculate with yeast, propagate, transform yeast, express vector, recover encapsidated particle
05/01/2003US20030082741 Nucleotide sequences coding polypeptide for use as tool in genetic engineering
05/01/2003US20030082523 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
05/01/2003US20030082518 Genetic engineering; quantitative analysis; medical diagnosis
05/01/2003US20030082210 Sequence determination; calibration
05/01/2003US20030082209 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
05/01/2003US20030082206 Method of preserving infectious recombinant viruses, aqueous viral suspension, and use as medicament
05/01/2003US20030082204 Mixture of attenuated genetic engineered virus and carrier
05/01/2003US20030082150 Recombinant adenoviral vectors for human tumour gene therapy
05/01/2003US20030082143 Filamentous phage particles having a ligand on surface for delivering a therapeutic gene to a cell; gene therapy
05/01/2003CA2470197A1 Mycobacterial genes down-regulated during latency
05/01/2003CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003CA2429505A1 Prevention of recurrent viral disease
04/2003
04/30/2003CN1413733A Foot-and-mouth disease virus antigen preservation technology
04/30/2003CN1413732A Foot-and-mouth disease virus antigen dilution technology
04/29/2003US6555368 Single-chain antibody introduced into the minor capsid proteins so that the adenoviral vector can be targeted to a particular cell type
04/29/2003US6555346 Selecting a recombinant baculovirus expressing the protein, growing insect cells in a culture vessel and infecting the cells with an inoculum of baculovirus at a cell density of 1 x 105-5 x 106 cells/ml
04/29/2003US6555345 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
04/29/2003US6555331 Bacteriophage assay
04/29/2003US6555313 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
04/29/2003US6555311 Hepatitis B variants exhibiting complete or partial resistance to nucleoside analogues and/or reduced interactivity with antibodies to viral surface components; use determining if a strain will be antiviral drug resistant
04/29/2003US6555107 Packaging cell
04/29/2003CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
04/29/2003CA2071567C Blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatment
04/24/2003WO2003033700A1 Method for inhibiting the replication of viruses
04/24/2003WO2003033145A1 Photocatalytic material and utilization thereof
04/24/2003WO2003005964A3 Recombinant vsv for the treatment of tumor cells
04/24/2003WO2002097072A3 Influenza vaccine composition
04/24/2003WO2002045431A3 Genetically engineered herpes virus for the treatment of cardiovascular disease
04/24/2003WO2002018585A8 Packaging of positive-strand rna virus replicon particles
04/24/2003WO2001079456A3 Materials and methods relating to increasing viral titre
04/24/2003US20030078411 Adeno-associated virus capsid immunologic determinants
04/24/2003US20030078410 Expression vector for use in the transfer of genes and preparation of vaccines
04/24/2003US20030077819 Oncolytic virus therapy
04/24/2003US20030077813 Structure of adenovirus bound to cellular receptor car
04/24/2003US20030077705 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and ischemia-reperfusion injury
04/24/2003US20030077641 Methods of suppressing microglial activation and systemic inflammatory responses
04/24/2003US20030077579 Diagnostic assay
04/24/2003US20030077578 Diagnostic assay
04/24/2003US20030077252 Vaccination against plaque forming diseases; inhibiting aggregation of amyloid in mammal and/or to cause disaggregation of amyloid; treating brain disorder, Alzheimer's disease
04/24/2003US20030077251 Replicons derived from positive strand RNA virus genomes useful for the production of heterologous proteins
04/24/2003CA2463805A1 Photocatalytic material and utilization thereof
04/23/2003EP1304382A2 Production of peptides in plants as viral coat protein fusions
04/23/2003EP1303613A2 Rescue of canine distemper virus from cdna
04/23/2003EP1303608A2 Zinc finger domain recognition code and uses thereof
04/23/2003EP1303302A2 Use of strains of the parapox ovis virus against organ fibrosis
04/23/2003EP0817858B1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
04/23/2003CN1413258A Invasive bacterial vectors for expressing alphavirus replicons
04/23/2003CN1413219A Molecular structure of RHD negative genes locus
04/23/2003CN1413120A Method of inactivating pathogens
04/23/2003CN1412314A Virus expression veclor of tomato flower-leaf virus low virulent strain K
04/23/2003CN1412304A Method for controlling lepidopterous nocturnal moth pests by using quickly-acting polyhedron virus
04/23/2003CN1412303A Recombinant gland related virus expressing human kallikrein, its preparation method and application
04/23/2003CN1412295A Oncolytic microorganism expressing heat shock protein and its application
04/22/2003US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof
04/22/2003US6551824 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318
04/22/2003US6551823 EBV-infected stomach cancer cell line
04/22/2003US6551597 Vaccine compositions for human papillomavirus
04/22/2003CA2152941C Cytopathic viruses for therapy and prophylaxis of neoplasia
04/22/2003CA2102623C Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
04/22/2003CA2091678C Viral defective vaccine produced by transcomplementing cell line
04/17/2003WO2003031602A1 The oncolytic microorganisms expressing hsp and uses thereof
04/17/2003WO2003031583A2 Generation of virus-like particles by vsv
04/17/2003WO2003031567A2 Precursor conversion screening methods
04/17/2003WO2003031014A1 Separation medium, its preparation and its use
04/17/2003WO2003030933A1 Recombinant rabies vaccine and methods of preparation and use
04/17/2003WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
04/17/2003WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof
04/17/2003US20030074691 Resistance to viruses and viroids in transgenic plants and animals expressing dsRNA-binding protein
04/17/2003US20030074681 Replication defective retroviral vector for use as gene transfer tool in genetic engineering
04/17/2003US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
04/17/2003US20030073659 Encapsulation of virus; genetic engineering; packaging signal
04/17/2003US20030073232 Methods and vector constructs useful for production of recombinant AAV
04/17/2003US20030073223 For use in vaccines
04/17/2003US20030073104 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
04/17/2003US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development
04/17/2003US20030073072 Chimeric adenoviruses
04/17/2003US20030072773 Vaccines
04/17/2003US20030072772 Sub-unit vaccine for infectious pancreatic necrosis virus
04/17/2003US20030072771 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
04/17/2003US20030072753 Virus-like particles for the induction of autoantibodies
04/17/2003CA2463093A1 Separation medium, its preparation and its use
04/16/2003EP1301637A2 Dna vaccines encoding hiv accessory proteins
04/16/2003EP1301616A2 Bicistronic influenza viruses comprising two genes in tandem
04/16/2003EP1301615A2 Adenovirus vectors comprising introns
04/16/2003EP1301613A2 Modified virus having an altered tropism
04/16/2003EP1301612A2 Method and composition for targeting an adenoviral vector
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 267